Structure and function of lipopolysaccharides.

[1]  Adrian Ozinsky,et al.  Toll-like receptors: key mediators of microbe detection. , 2002, Current opinion in immunology.

[2]  K. Fukase,et al.  Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. , 2001, International immunology.

[3]  P. Tobias,et al.  MD-2 binds to bacterial lipopolysaccharide. , 2001, Journal of endotoxin research.

[4]  Dirk E. Smith,et al.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.

[5]  R. Medzhitov,et al.  TIRAP: an adapter molecule in the Toll signaling pathway , 2001, Nature Immunology.

[6]  M. Arditi,et al.  Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling1 , 2001, The Journal of Immunology.

[7]  R. Ulevitch,et al.  Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex , 2001, The Journal of Biological Chemistry.

[8]  A. Aderem,et al.  Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism , 2001, Nature Immunology.

[9]  M. J. Cody,et al.  Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages , 2001, Infection and Immunity.

[10]  M. Nishijima,et al.  Cutting Edge: Gln22 of Mouse MD-2 Is Essential for Species-Specific Lipopolysaccharide Mimetic Action of Taxol1 , 2001, The Journal of Immunology.

[11]  T. McIntosh,et al.  Preparation and Preclinical Evaluation of a Novel Liposomal Complete-Core Lipopolysaccharide Vaccine , 2000, Infection and Immunity.

[12]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[13]  J. Brisson,et al.  Structure of the Bordetella pertussis 1414 endotoxin , 2000, FEBS letters.

[14]  P. Ricciardi-Castagnoli,et al.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Monks,et al.  Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. , 2000, The Journal of clinical investigation.

[16]  T. Kirikae,et al.  Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. , 2000, Biochemical and biophysical research communications.

[17]  T. Yoshida,et al.  Mouse Toll-like Receptor 4·MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol* , 2000, The Journal of Biological Chemistry.

[18]  S. Opal,et al.  Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. , 1999, The Journal of infectious diseases.

[19]  J. Govan,et al.  Lipopolysaccharide chemotypes of Burkholderia cepacia. , 1999, Journal of medical microbiology.

[20]  R. Thieringer,et al.  Internalization of Monomeric Lipopolysaccharide Occurs after Transfer Out of Cell Surface Cd14 , 1999, The Journal of experimental medicine.

[21]  D. Hood,et al.  Haemophilus influenzae lipopolysaccharide. , 1999, Biochemical Society transactions.

[22]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[23]  W. Goldman,et al.  Signalling and cellular specificity of airway nitric oxide production in pertussis , 1999, Cellular microbiology.

[24]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[25]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[26]  M. Sela,et al.  Activation of Murine Macrophages by Lipoprotein and Lipooligosaccharide of Treponema denticola , 1999, Infection and Immunity.

[27]  S. Wright.  Toll, A New Piece in the Puzzle of Innate Immunity , 1999, The Journal of experimental medicine.

[28]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[29]  D. Hansen,et al.  Klebsiella pneumoniae Lipopolysaccharide O Typing: Revision of Prototype Strains and O-Group Distribution among Clinical Isolates from Different Sources and Countries , 1999, Journal of Clinical Microbiology.

[30]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[31]  R. Thieringer,et al.  Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement. , 1998, Immunity.

[32]  M. Blaser,et al.  Simultaneous Expression of Type 1 and Type 2 Lewis Blood Group Antigens by Helicobacter pyloriLipopolysaccharides , 1998, The Journal of Biological Chemistry.

[33]  A. Moran,et al.  Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. , 1997, The Journal of infectious diseases.

[34]  B. Lindner,et al.  Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides , 1997, Journal of bacteriology.

[35]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[36]  M. Wurfel,et al.  Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. , 1997, Journal of immunology.

[37]  B. Appelmelk,et al.  Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. , 1996, FEMS immunology and medical microbiology.

[38]  J. Goldberg,et al.  Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. , 1996, Trends in microbiology.

[39]  R. Rest,et al.  Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate , 1996, Infection and immunity.

[40]  J. Goldberg,et al.  Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections , 1996, Science.

[41]  A. Cox,et al.  Structures of the two polymers present in the lipopolysaccharide of Burkholderia (Pseudomonas) cepacia serogroup O4. , 1995, European journal of biochemistry.

[42]  I. Poxton,et al.  Biological activity of Bacteroides lipopolysaccharide--reappraisal. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  G. Barclay,et al.  Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species , 1995, Infection and immunity.

[44]  G. Barclay,et al.  A re-appraisal of the biological activity of bacteroides LPS. , 1995, Journal of medical microbiology.

[45]  M. Jacques,et al.  High-molecular-mass lipopolysaccharides are involved in Actinobacillus pleuropneumoniae adherence to porcine respiratory tract cells , 1994, Infection and immunity.

[46]  V. Reinhold,et al.  Detailed structural characterization of lipid A: electrospray ionization coupled with tandem mass spectrometry. , 1994, Analytical biochemistry.

[47]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.

[49]  M. Nowak,et al.  Adaptive evolution of highly mutable loci in pathogenic bacteria , 1994, Current Biology.

[50]  J. Mcghee,et al.  Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines , 1993, Infection and immunity.

[51]  P. Merino,et al.  Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? , 1993, Critical care medicine.

[52]  G. Ramsay,et al.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides , 1993, Infection and immunity.

[53]  M. Kastowsky,et al.  Effect of pH on solubility and ionic state of lipopolysaccharide obtained from the deep rough mutant of Escherichia coli. , 1993, Biochemistry.

[54]  M. Kastowsky,et al.  Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide. , 1993, Immunobiology.

[55]  T. Kirikae,et al.  The chemical structure of bacterial endotoxin in relation to bioactivity. , 1993, Immunobiology.

[56]  M. Apicella,et al.  Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. , 1993, Immunobiology.

[57]  H. Flad,et al.  Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures , 1992, Infection and immunity.

[58]  J. Hildebrandt,et al.  Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterization of immunostimulating contaminants in a batch of synthetic lipid X. , 1990, The Journal of biological chemistry.

[59]  A. Weintraub,et al.  Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. , 1989, Journal of immunology.

[60]  B. Lindner,et al.  Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. , 1988, European journal of biochemistry.

[61]  A. Cross,et al.  Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. , 1987, The Journal of clinical investigation.

[62]  H. Brade,et al.  Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[63]  E. Moxon,et al.  Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. , 1986, Microbial pathogenesis.

[64]  K. Joiner,et al.  C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. , 1986, Journal of immunology.

[65]  H. Mayer,et al.  Lipopolysaccharides from Yersinia pestis. Studies on lipid A of lipopolysaccharides I and II. , 1985, European journal of biochemistry.

[66]  D L Diedrich,et al.  Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. , 1985, Canadian journal of microbiology.

[67]  E. Rietschel,et al.  Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. , 1985, European journal of biochemistry.

[68]  R. Tharanathan,et al.  The structure of the polysaccharide moiety of Rhodopseudomonas sphaeroides ATCC 17023 lipopolysaccharide. , 1984, European journal of biochemistry.

[69]  M. Frank,et al.  Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide , 1984 .

[70]  T. Pitt,et al.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa , 1984, Infection and immunity.

[71]  K. Tanamoto,et al.  Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate , 1984, Infection and immunity.

[72]  R. Hancock,et al.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains , 1983, Infection and immunity.

[73]  R. Hancock,et al.  Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains , 1983, Journal of bacteriology.

[74]  S. Wilkinson,et al.  Studies of lipopolysaccharides from Pseudomonas aeruginosa. , 1975, European journal of biochemistry.

[75]  J. Spitzer,et al.  Cellular and molecular aspects of endotoxin reactions : proceedings of the 1st Congress of the International Endotoxin Society, San Diego, 9-12 May 1990 , 1990 .

[76]  A. Weintraub,et al.  Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. , 1990, Reviews of infectious diseases.

[77]  E. Rietschel,et al.  Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. , 1987, Progress in clinical and biological research.

[78]  L. Larsson,et al.  A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis , 1987, Nature.